Status:
RECRUITING
Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Lead Sponsor:
MSD Italia S.r.l.
Conditions:
Cytomegalovirus Infection
Hematopoietic Stem Cells Transplantation
Eligibility:
All Genders
Up to 18 years
Brief Summary
This observational retrospective analysis will provide useful information for clinicians and payers, and local guidelines committee members, to improve the understanding of Cytomegalovirus clinical an...
Detailed Description
This is an observational retrospective analysis from the main pediatric centers in Italy (approximately 5 sites). The selected sites will be the most representative of Italy because they perform about...
Eligibility Criteria
Inclusion
- Patients from birth to less than 18 years of age (at the moment of the allogeneic HSCT);
- Patients who received allogeneic HSCT between January 2018 and June 2020;
- Patients (or their legally acceptable representatives) must have signed and dated the Informed Consent \& Privacy Form (ICF), if applicable.
Exclusion
- Letermovir use at any time
Key Trial Info
Start Date :
May 9 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT06916195
Start Date
May 9 2025
End Date
October 31 2025
Last Update
July 20 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Giannina Gaslini, Trapianto di Cellule Staminali Emopoietiche, Dipartimento di Onco-Ematologia Pediatrica
Genova, Italy
2
Ospedale San Gerardo, Clinica Pediatrica
Monza, Italy, 20900
3
Azienda Ospedale-Università di Padova, Clinica di Oncoematologia Pediatrica
Padua, Italy, 35128
4
IRCCS Ospedale Pediatrico Bambino Gesù, Dipartimento di Pediatria Ematologia e Oncologia
Roma, Italy, 00165